Colorectal Cancer Information
This information is intended for U.S. residents only.
Colorectal Cancer
Colorectal cancer—cancer of the colon or rectum—is the third most frequently diagnosed cancer in the US (excluding skin cancer), but it is unique in that it is preventable with early detection.
It is usually slow growing, and the first sign of potential colorectal cancer is often a precancerous polyp or lesion. Since polyps in the colon can develop into cancer, early detection and removal is essential.
Colonoscopy is the key to early detection and prevention. People without elevated risk factors should have their first colonoscopy at the age of 50 and subsequent colonoscopies every 10 years after that.
Anyone with identified risk factors such as a family history of colorectal cancer should be screened earlier and more frequently.
Early Detection
Regular screenings and early detection are the most effective ways to fight colorectal cancer. Identifying and removing precancerous polyps and lesions can stop colon cancer before it starts. Even if cancer
has developed, the 5-year survival rate when it is treated while still confined to the colon is over 90%.
MoviPrep® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is indicated for cleansing of the
colon as a preparation for colonoscopy in adults 18 years of age or older. MoviPrep is contraindicated in patients who have had a severe hypersensitivity reaction
to any of its components. MoviPrep should be used with caution in patients using concomitant medications that increase the risk of electrolyte abnormalities, in patients with known or suspected hyponatremia,
severe ulcerative colitis, ileus, gastrointestinal obstruction or perforation, gastric retention, toxic colitis, toxic megacolon, or glucose-6-phosphate dehydrogenase deficiency. In clinical trials, abdominal
distention, anal discomfort, thirst, nausea, and abdominal pain were the most common adverse reactions to MoviPrep administration. MoviPrep contains a maximum of 2.33 mg of phenylalanine per treatment.
Consult with your physician to see if this product is right for you.
For complete Prescribing Information, please click here.
For product information, adverse event reports, and product complaint reports please call:
Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
Email: